Chheda, Zinal S <br/><br/>
Novel and shared neoantigen derived from histone 3 variant H3.3K27M mutation for glioma T cell therapy.  [electronic resource] 

 -  The Journal of experimental medicine  01 2018 
 - 141-157 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1540-9538 
<br/><br/><label>Standard No.: </label>10.1084/jem.20171046  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adoptive Transfer<br/>Amino Acid Sequence<br/>Amino Acids<br/>Animals<br/>Antigen Presentation<br/>Antigens, Neoplasm--chemistry<br/>Chromatography, Liquid<br/>Disease Models, Animal<br/>Epitope Mapping<br/>Female<br/>Glioma--genetics<br/>HLA-A Antigens--immunology<br/>Histones--chemistry<br/>Humans<br/>Immunotherapy, Adoptive<br/>Mice<br/>Mice, Transgenic<br/>Mutation<br/>Peptides--chemistry<br/>Protein Binding<br/>Receptors, Antigen, T-Cell--genetics<br/>T-Cell Antigen Receptor Specificity--immunology<br/>T-Lymphocytes--immunology<br/>Tandem Mass Spectrometry<br/>Xenograft Model Antitumor Assays